Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis

被引：30
作者：
Burkhardt, Olaf [1 ]
Joukhadar, Christian [2 ]
Traunmueller, Friederike [2 ]
Hadem, Johannes [3 ]
Welte, Tobias [1 ]
Kielstein, Jan T. [1 ]
机构：
[1] Hannover Med Sch, Dept Pulm Med, D-3000 Hannover, Germany
[2] J&P Med Res Ltd, Vienna, Austria
[3] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 01期
关键词：
gram-positive infections; endocarditis; renal replacement therapy;
D O I：
10.1093/jac/dkm405
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：224 / 225
页数：3
相关论文
共 8 条
  • [1] Daptomycin clearance during modeled continuous renal replacement therapy
    Churchwell, Mariann D.
    Pasko, Deborah A.
    Mueller, Bruce A.
    [J]. BLOOD PURIFICATION, 2006, 24 (5-6) : 548 - 554
  • [2] Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis
    Czock, David
    Huesig-Linde, Cordula
    Langhoff, Anita
    Schoepke, Timo
    Hafer, Carsten
    de Groot, Kirsten
    Swoboda, Stefanie
    Kuse, Ernst
    Haller, Hermann
    Fliser, Danilo
    Keller, Frieder
    Kielstein, Jan T.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06): : 1263 - 1268
  • [3] Population pharmacokineties of daptomycin
    Dvorchik, B
    Arbeit, RD
    Chung, J
    Liu, S
    Knebel, W
    Kastrissios, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 2799 - 2807
  • [4] Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
    Dvorchik, BH
    Brazier, D
    DeBruin, MF
    Arbeit, RD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1318 - 1323
  • [5] Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis
    Fliser, D
    Kielstein, JT
    [J]. NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (01): : 32 - 39
  • [6] Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria
    Johnson, Alan
    [J]. FUTURE MICROBIOLOGY, 2006, 1 (03) : 255 - 265
  • [7] Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis
    Kielstein, JT
    Czock, D
    Schöpke, T
    Hafer, C
    Bode-Böger, SM
    Kuse, E
    Keller, F
    Fliser, D
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (01) : 51 - 56
  • [8] Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates
    Pankuch, GA
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 3012 - 3014
1